Ailish Hanly, MD
Assistant ProfessorCards
About
Research
Publications
2026
Presentation and Management of Peristomal Pyoderma Gangrenosum.
D'Aquila M, Schultz K, Hanly A, Giannettino J, Leeds I. Presentation and Management of Peristomal Pyoderma Gangrenosum. Diseases Of The Colon & Rectum 2026 PMID: 42644322, DOI: 10.1097/dcr.0000000000004368.Peer-Reviewed Original ResearchOstraceous psoriasis in end-stage renal disease: A delayed phenotype switch from dupilumab treated with guselkumab
Craver A, McKenzie P, Hanly A, Vesely M. Ostraceous psoriasis in end-stage renal disease: A delayed phenotype switch from dupilumab treated with guselkumab. JAAD Case Reports 2026, 74: 14-17. PMID: 42381818, PMCID: PMC13316689, DOI: 10.1016/j.jdcr.2026.05.049.Peer-Reviewed Original ResearchThe Histopathological Features of Secondary Syphilis: A Case Series
Hanly A, Panse G, Myung P, Ko C. The Histopathological Features of Secondary Syphilis: A Case Series. Journal Of Cutaneous Pathology 2026, 53: 724-730. PMID: 41948836, DOI: 10.1111/cup.70113.Peer-Reviewed Original ResearchA Solitary Axillary Subcutaneous Mass.
Williams M, Hanly A, Turner N, Leventhal J. A Solitary Axillary Subcutaneous Mass. Cutis 2026, 117: e12-e14. PMID: 42411897, DOI: 10.12788/cutis.1383.Peer-Reviewed Original ResearchUnusual Aggregates of Eosinophilic Proteinaceous Material in the Eccrine Unit of a Patient With Hypohidrosis
Hanly A, Cowper S, Rivera A, Zubek A. Unusual Aggregates of Eosinophilic Proteinaceous Material in the Eccrine Unit of a Patient With Hypohidrosis. Journal Of Cutaneous Pathology 2026, 53: 481-484. PMID: 41651553, DOI: 10.1111/cup.70069.Peer-Reviewed Original Research
2025
Structural Insights: What Makes Some PDE4 Inhibitors More Effective in Inflammatory Dermatoses.
Issa N, Wang J, Hanly A, Ho M, Obagi S, Damiani G, Del Rosso J, Kang Y, Bunick C. Structural Insights: What Makes Some PDE4 Inhibitors More Effective in Inflammatory Dermatoses. The Journal Of Clinical And Aesthetic Dermatology 2025, 18: 18-21. PMID: 40778010, PMCID: PMC12327561.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsAtypical bullous systemic lupus erythematosus with features of linear IgA bullous dermatosis
Jiang R, Zhou A, Ko C, Girardi M, Hanly A, Xie C, Preda-Naumescu A, Gehlhausen J, Tomayko M. Atypical bullous systemic lupus erythematosus with features of linear IgA bullous dermatosis. JAAD Case Reports 2025, 58: 74-76. PMID: 40129457, PMCID: PMC11930652, DOI: 10.1016/j.jdcr.2024.12.040.Peer-Reviewed Original Research
2024
Spiny Keratoderma: Clinical and Histopathological Findings in a Series of 3 Cases
Hanly A, Turner N, Ko C, Panse G. Spiny Keratoderma: Clinical and Histopathological Findings in a Series of 3 Cases. American Journal Of Dermatopathology 2024, 46: 439-442. PMID: 38574081, DOI: 10.1097/dad.0000000000002705.Peer-Reviewed Original ResearchThe CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma
Wu M, Hanly A, Gibson F, Fisher R, Rogers S, Park K, Zuger A, Kuang K, Kalin J, Nocco S, Cole M, Xiao A, Agus F, Labadorf A, Beck S, Collard M, Cole P, Alani R. The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma. Journal Of Clinical Investigation 2024, 134: e171063. PMID: 38300709, PMCID: PMC10940100, DOI: 10.1172/jci171063.Peer-Reviewed Original Research
2023
Prurigo Nodularis: Moving Forward.
Hanly A, Watsky K. Prurigo Nodularis: Moving Forward. Cutis 2023, 112: 262-263. PMID: 38290066, DOI: 10.12788/cutis.0903.Commentaries, Editorials and Letters